Back to EPRX

MARSHALL WACE, LLP → EPRX

MARSHALL WACE, LLP EPRX Position History

Eupraxia Pharmaceuticals Inc. • Healthcare

Quarters held
8
Latest value
$1.2M
Q3 2026
Peak value
$1.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$174K
Q4 2025$1M
Q1 2026$166K
Q1 2026$979K
Q2 2026$152K
Q2 2026$893K
Q3 2026$209K
Q3 2026$1.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.2M135.2K——
Q3 2026$209K23.0K——
Q2 2026$893K135.2K——
Q2 2026$152K23.0K——
Q1 2026$979K135.2K——
Q1 2026$166K23.0K——
Q4 2025$1M135.2K——
Q4 2025$174K23.0K——

Other funds holding EPRX

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B